Company intelligence / Profile preview

Mott Family Capital

Wilmington, Delaware, United States

Ownership: Private
Development stage: Other

Overview

Mott Family Capital is a private family investment vehicle associated with biotech executive and investor David Mott. Public references describe it as the entity through which David Mott acted as a private investor after his tenure at New Enterprise Associates and before moving to Sphinx Mountain Capital. Although it has strong ties to the biotechnology and healthcare investing ecosystem through David Mott's background, it does not appear to be an operating biotechnology, pharmaceutical, or healthcare company developing therapeutic products. Instead, it is best characterized as a private investment or family office entity.

Industry: Investors

Beyond the preview

Go deeper on Mott Family Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mott Family Capital.

Explore the full profile